New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settingsFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Affordability of adult tuberculosis vaccination in India and China: A dynamic transmission model-based analysisFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and IndonesiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in ChinaFriday, August 9, 2024Availability, Epidemiological impactRead More
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccinesFriday, August 9, 2024Acceptability, Acceptability and demand, Implementation strategies and feasibilityRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
